Results For "WOKADINE-acquisition"

1 News Found

CORONA Remedies FY26 revenue rises 17.3% to Rs. 1,403 crore

News | May 12, 2026

CORONA Remedies FY26 revenue rises 17.3% to Rs. 1,403 crore

The company’s PAT rose 43.7% year-on-year to Rs. 45.3 crore in Q4FY26 from Rs. 31.5 crore

Latest Stories

Comau and OMRON join hands to advance industrial automation globally

Merck Foundation reaffirms 14-year commitment to women empowerment

Plus Therapeutics subsidiary clears key Medicare milestone

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Duraisamy Rajan Palani Founder and CEO, Archimedis Digital

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

Kavinder Beniwal Chief Operational Officer, Motorica India

Packaging